Technology

AddToAny

Google+ Facebook Twitter Twitter

News flow cytometer

Merck, a leading science and technology company, has now launched its new CellStream flow cytometry system.

New flow cytometer

The new product for the life science industry was launched at the 33rd Congress of the International Society for the Advancement of Cytometry, which took place on April 28 to May 2 in Prague.

Merck’s new CellStream benchtop flow cytometry system is a compact and customisable flow cytometer that uses a camera for detection.

Its unique optics system and design give researchers unparalleled sensitivity for analyzing cells and submicron particles, plus the flexibility of up to seven lasers.

The optical system is based on patented technology unique to the company’s Amnis flow cytometers.

merckgroup.com

Related Articles

HOW WELL DO CANCER DRUGS HIT THEIR TARGETS?

Scientists have developed a technique that allows them to measure how well cancer drugs reach their targets in the body.

“CANCEROUS CELLS WORK TOGETHER TO INFILTRATE THE BRAIN”

Scientists have discovered that cancerous cells in an aggressive type of childhood brain tumour work together to infiltrate the brain.

MAGNETS ISOLATE CIRCULATING TUMOUR CELLS

Scientists claim that magnets could be used in the body to detect tumour cells that other diagnostic techniques might miss.

my ibms Microscopic of koilocyte cell criteria of hpv human papilloma virus infection pap smear shutterstock

HPV primary screening

Following a review of its delivery strategy, NHS England has agreed to begin a one-stage procurement process to reconfigure provider laboratories to support the roll-out of Human Papilloma Virus (HPV) primary screening into the NHS Cervical Cancer Screening Programme in England.

Top